| Dr Danilo Ruiz, MD | |
|
1700 W Townline St, Creston, IA 50801-1054 | |
| (641) 782-7091 | |
| (641) 782-3830 |
| Full Name | Dr Danilo Ruiz |
|---|---|
| Gender | Male |
| Speciality | Surgery |
| Location | 1700 W Townline St, Creston, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710044037 | NPI | - | NPPES |
| 1131979 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 20349 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Danilo Ruiz, MD 1700 W Townline St, Creston, IA 50801-1054 Ph: (641) 782-7091 | Dr Danilo Ruiz, MD 1700 W Townline St, Creston, IA 50801-1054 Ph: (641) 782-7091 |
News Archive
Results from the DELTA trial indicate no significant differences in progression-free or overall survival after treatment with docetaxel versus erlotinib in non-small-cell lung cancer patients unselected for their epidermal growth factor receptor mutation status.
A Health Protection Agency study has shown a sharp fall in the number of confirmed cases of Haemophilus influenzae type b (Hib) disease following the introduction of a Department of Health booster campaign, the Agency's Board heard today.
MedAvante, Inc., the leader in centralized expert evaluation of central nervous system (CNS) disorders, and Rexahn Pharmaceuticals, Inc. a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, announced that Rexahn will use MedAvante 's Remote Centralized Ratings™ in their randomized, double-blind, placebo-controlled Phase 2b clinical study assessing the efficacy of Serdaxin® in patients with major depressive disorder (MDD).
Janssen Pharmaceuticals, Inc. and its development partner, Bayer HealthCare, today announced the initiation of CALLISTO, a new comprehensive clinical research program for their novel oral anticoagulant, rivaroxaban, in patients with active cancer. The studies are evaluating the medicine for the prevention and treatment of life-threatening blood clots in patients with a wide range of cancer types.
› Verified 8 days ago
Dr. Amy Slee Hynek Mcfarland, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1610 W Townline St, Creston, IA 50801 Phone: 641-782-2131 Fax: 641-782-6425 | |
Robert M Kuhl, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1610 W Townline St, Suite 200, Creston, IA 50801 Phone: 641-782-2131 Fax: 641-782-6425 | |
Dr. Heather Anna Osterbrink, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1610 W Townline St, Suite 110, Creston, IA 50801 Phone: 641-782-3887 Fax: 641-782-3941 |